NBIX · earnings call history
Neurocrine Biosciences Q2 FY26 — Record Sales and Pipeline Advancement
Read the briefNeurocrine Biosciences Q1 FY26 — Record Sales and Robust Pipeline Advancement
Read the briefBrowse all US companies on the earnings-call register.